Article Text

Download PDFPDF
Pupilloplasty to prevent dexamethasone intravitreal implant migration to anterior chamber
  1. Joana Medeiros Pinto1,2,
  2. Carlos Marques-Neves1,2,3
  1. 1 Ophthalmology, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, 1649-035, Lisbon, Portugal
  2. 2 Ophthalmology, Faculty of Medicine, Universidade de Lisboa, 1649-028, Lisbon, Portugal
  3. 3 Vision Sciences Study Center, Faculty of Medicine, Universidade de Lisboa, 1649-028, Lisboa, Portugal
  1. Correspondence to Professor Carlos Marques-Neves,{at}

Statistics from


We present a case of a 84-year-old man, treated with dexamethasone intravitreal implant (Ozurdex®) for Irvine-Gass syndrome after complicated cataract surgery, with subsequent vitrectomy and retropupillar positioning of iris-fixated intraocular lens. Four weeks after the implantation, the patient presented with the implant in the anterior chamber. To prevent corneal oedema, the implant was removed the day after. After evaluating the anterior segment, the communication between the vitreal cavity and the anterior chamber, through which the implant has migrated, was found (figure 1A). The cystoid macular oedema (CME) reappeared (figure 2A …

View Full Text


  • Contributors Both authors were involved in conception and design. JMP was responsible for acquisition of data and drafting the article; CMN revised it critically. Both approve the version to be published.

    Both agree to be accountable for the article and to ensure that all questions regarding the accuracy or integrity of the article are investigated and resolved.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.